Hui Meng
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Research and Splicing
- Epigenetics and DNA Methylation
Papers in
-
- Cancer-related molecular mechanisms research 8
-
- Traditional Chinese Medicine Analysis 5
- Co-authors
- Kai You Wang (4 shared papers)Yun Bai (9 shared papers)Juan Li (2 shared papers)Yun Bai (1 shared paper)Li‐Wen Hu (3 shared papers)Kang Yang (4 shared papers)Hua Feng (11 shared papers)Yuanyuan Wu (2 shared papers)
- Journals
- Journal of Ethnopharmacology (3 papers)Cancer Research (3 papers)Chinese Journal of Integrative Medicine (2 papers)Neurological Research (2 papers)Frontiers in Physiology (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Hui Meng
79 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 117
- Cancer Research 759
- Molecular Biology 1.1k
- Developmental Biology 28
- Developmental Neuroscience 43
- Pathology and Forensic Medicine 179
Countries citing papers authored by Hui Meng
This map shows the geographic impact of Hui Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Meng more than expected).
Fields of papers citing papers by Hui Meng
This network shows the impact of papers produced by Hui Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Meng. The network helps show where Hui Meng may publish in the future.
Co-authors
The 25 scholars most cited alongside Hui Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 82 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 240 | |
| 2 | 2015 | 206 | |
| 3 | 2017 | 136 | |
| 4 | 2016 | 102 | |
| 5 | 2008 | 101 | |
| 6 | 2012 | 94 | |
| 7 | 2010 | 89 | |
| 8 | 2014 | 61 | |
| 9 | 2017 | 61 | |
| 10 | 2012 | 56 | |
| 11 | 2014 | 56 | |
| 12 | MicroRNA-330-3p functions as an oncogene in human esophageal cancer by targeting programmed cell death 4. | 2015 | 56 |
| 13 | 2020 | 56 | |
| 14 | 2011 | 53 | |
| 15 | 2018 | 51 | |
| 16 | 2018 | 42 | |
| 17 | 2015 | 41 | |
| 18 | 2013 | 39 | |
| 19 | 2017 | 39 | |
| 20 | 2012 | 37 |
About Hui Meng
Hui Meng is a scholar working on Cancer Research, Complementary and alternative medicine, Molecular Biology, Pathology and Forensic Medicine and Oncology, having authored 82 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (8 papers), RNA modifications and cancer (6 papers), Renal cell carcinoma treatment (5 papers), Epigenetics and DNA Methylation (5 papers), Traditional Chinese Medicine Analysis (5 papers), Immunotherapy and Immune Responses (4 papers), Vestibular and auditory disorders (3 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Cancer Research (759 citations), Molecular Biology (1.1k citations), Developmental Biology (28 citations), Developmental Neuroscience (43 citations) and Pathology and Forensic Medicine (179 citations). Hui Meng has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Kai You Wang, Yun Bai, Juan Li, Yun Bai, Li‐Wen Hu, Kang Yang, Hua Feng, Yuanyuan Wu, Xuedan Chen and S. Jack Hu. Their work appears in journals such as Journal of Ethnopharmacology, Cancer Research, Chinese Journal of Integrative Medicine, Neurological Research and Frontiers in Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.